Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic.

Slides:



Advertisements
Similar presentations
EQUIP Training session 2
Advertisements

Implementing NICE guidance
A Quality Colonoscopy: Are You Providing One?
T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
EQUIP Training session 1
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
CT COLONOSCOPY. Turki Alhazmi,MB.CHB, FRCPC, dABR Interventional Radiology-Body MRI Ass. Prof. Faculty of Medicine Umm Al Qura University Makkah-Saudi.
When Is A Colonoscopy Not a Colonoscopy
Bowel Screening in Scotland – Current Challenges and Possible Solutions Prof. Bob Steele Ninewells Hospital, University of Dundee.
1 The Chemoprevention of Sporadic Colorectal Cancer Issues Surrounding a Benefit/Risk Analysis in Clinical Trials Mark Avigan MD CM Medical Officer Division.
Benchmarking For Colonoscopy
Validation of a Simple Classification System for Endoscopic Diagnosis of Small Colorectal Polyps Using Narrow-Band Imaging David G. Hewett GASTROENTEROLOGY.
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
Colorectal carcinoma Dr.Mohammadzadeh.
CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
Perspectives from the Waitemata Bowel Screening Pilot team -The Endoscopic view Paul Frankish Lead Endoscopist.
The effects of inadequate preparation quality for colonoscopy Eric Sherer and Michael Catlin August 20 th, 2010 HSR&D Work-in-Progress 1.
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
Sessile Serrated Adenomas: A Case Presentation Kevin Witt, PGY3 Justin Whitt, MD IU Health Ball Memorial Family Medicine Residency.
Chromocolonoscopy Sashi Sagi MBBS Asst Prof of Clinical Medicine Indiana University.
Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without.
This article and any supplementary material should be cited as follows: Rabadi MH, Vincent AS. Colonoscopic lesions in veterans with spinal cord injury.
Optical Diagnosis for Colorectal Polyps? Steve Schrock, MD, FAAFP November 5, 2015.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of.
Interval Colorectal Cancer 전임의 남지혁 Comparison of the Observed Incidence of Colorectal Cancer in the National Polyp Study Cohort with That.
1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 3 : 2013 F1 김태영
R4 채정민 / Prof 이창균. INTRODUCTION colonoscopy is a widely used screening tool for colorectal cancer adenoma detection rate (ADR) important quality indicator.
Dynamic patient position changes during colonoscope withdrawal increase adenoma detection : a randomized, crossover trial James E. East, MRCP, MD, Paul.
Dana Ben-Am Center for Autoimmune Diseases Department of Medicine ‘B’ Sheba Medical Center May 2010 Screening for Colorectal Cancer.
CLinical EValuation of the EndoRings: “The CLEVER study” Interim results of a randomized, multicenter, tandem colonoscopy study Introduction Adenomas can.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Comparative Study of Conventional Colonoscopy, Chromoendoscopy, and Narrow-Band Imaging Systems in Differential Diagnosis of Neoplastic and Nonneoplastic.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Clinical process indicators
Quality Indicators for Colonoscopy
BOWEL SCOPE SCREENING Dorset BCSP
The addition of histology to continuous audit has significantly increased adenoma detection rate in a private endoscopy unit AG Fraser 1, GD Gamble 1,
A Quality improvement initiative
27th Annual Winter CME Conference
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Volume 136, Issue 2, Pages e1 (February 2009)
Full-Spectrum Endoscopy Improves Adenoma Detection Compared to Conventional Colonoscopy PLUS Right-Colon Examination With Scope Retroflexion: A Randomized,
Jasper Vleugels PhD-student AMC
Repeat Colonoscopy Recommendations
A Visual Tour of Effective Colonoscopy
CRC Screening and Quality of Colonoscopy
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Volume 136, Issue 2, Pages e1 (February 2009)
Recent Advances in Endoscopy
Figure 1 Imaging of a depressed intramucosal carcinoma
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Colonoscopy and Diminutive Polyps: Hot or Cold Biopsy or Snare
Volume 136, Issue 4, Pages (April 2009)
Nonpolypoid (Flat and Depressed) Colorectal Neoplasms
Polyps of the Colon and Rectum
Advances in Endoscopic Imaging of Colorectal Neoplasia
A Visual Tour of Effective Colonoscopy
Recent Advances in Endoscopy
Tonya Kaltenbach, MD, William J. Sandborn, MD 
Sang Man Park, Min Kyu Jung, Seong Woo Jeon, Sung Kook Kim
Risks of interval colorectal cancer in a FIT-based screening program
Nasim Parsa, MD, Douglas K. Rex, MD  VideoGIE 
Presentation transcript:

Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic Imaging for Screening Colonoscopy in a Private Practice Setting- A Large Prospective Randomized Trial

Missed Adenomas 15-25% (Tandem-Colonoscopy-Studies)

Improvement of the Adenoma Detection Rate: Instrument modification of the colonoscopes Wide angle Magnifying glass cap Image Improvement Chromoendoscopy NBI with HDTV Autofluorescence

Total colonic dye staining No overall success, but subgroups of adenomas were found more frequently.

Technology for the Visualization of superficial structures of the mucosa by contrast enhancement. ConventionalNBI Narrow Band Imaging

BGR Infiltration depth und Imaging- Information Narrow Band Imaging

B. NBI: Flat adenoma 1

B. NBI: Flat adenoma 2

B. NBI: Flat adenoma 3

NBI-Colonoscopy-Study Background Three randomized trials from referral centers with a mixed patient population and conflicting results: 1.Rex, Gastroenterology 2007: ADR very high, further increase unlikely 2. Adler, Gut 2008: Not statistically significant difference, learning effect for conventional colonoscopy 3. Inoue, J. Gastroenterol. 2008: Significantly higher ADR

NBI-Study- Aims A much larger randomized study in a more homogeneous and realistic setting: a) focusing on screening colonoscopy only, b) involving only very experienced colonoscopists in a private practice setting.

NBI-Study- Outcome Parameter The main outcome parameter was the adenoma detection rate (ADR, number of polyps/number of patients examined) in the two groups. Secondary outcome measures included analysis of the total number of polyps, of flat adenomas (which have been shown repeatedly to have a higher risk of neoplastic development), of small adenomas (<1 cm), hyperplastic polyps with size determination, and of right-sided versus left- sided polyp location, in both groups.

NBI-Study: Patients and Methods Inclusion of all consecutive asymptomatic persons willing to undergo screening colonoscopy (reimbursed in Germany for those >55 years) Five private gastroenterology practices and six experienced examiners with a lifetime experience of a mean of colonoscopies (range ) over a mean of 19.4 years (range 15-28) After introduction of the colonoscope into the cecum, patients were randomly allocated to withdrawal of the instrument either using the NBI mode or conventional imaging, using wide-angle colonoscopes with HDTV imaging in both groups.

NBI-Study: Documented parameters Age and sex of the patient Type and dosage of sedation Examination time, both for instrument introduction and withdrawal Polyp characteristics: size (measured by open forceps or snare), shape (pedunculated/elevated, sessile and flat, the latter defined as maximal height of 1.3 mm), and location Histological findings after polyp removal, using snare polypectomy or forceps removal (for polyps <3 mm), or biopsy if there were contraindications Other lesions found, such as cancers, diverticula, inflammatory lesions etc.

Characteristics of patients, indications and colonoscopy performance in both groups Parameter NBI group (n = 625) Control group (n = 631) p Patient data Age (mean ± SD, range) 64.8 ± 6.5 (50 – 83) 64.3 ± 7.1 (31 – 87) 0.14 Sex, % male47.0%47.9%0.78 Sedation * None25.8%25.7%0.97 midazolam-based regimens45.6%44.4%0.35 midazolam plus propofol28.6%29.9%0.33 Mean examination time [min] Total 14.1 ± ± Introduction 5.6 ± ± Withdrawal 8.5 ± ± Cecal intubation rate99% 1.0 midazolam-based regimens included the administration of tramadol in 23.5% (both groups), which was given in addition to the combination midazolam and propofol in 10.7% and 10.9% of the entire groups.

Results for polyp detection rates in the NBI group and control group Polyp detection NBI group (n = 625) Control group (n = 631) p All polyps (n)346332n.s. Patients with polyps (%) n.s. Polyps per polyp carrier n.s. Polyps <10 mm317300n.s. Right-sided polyps100107n.s. Left-sided polyps246225n.s. Adenomas (n) n.s. Patients with adenomas22,4%21,7%n.s. Adenoma detection rate* n.s. Adenomas per adenoma carrier n.s. Adenomas < 10 mm178187n.s. Flat adenomas Adenomas with HGIN87n.s. Left-sided adenomas138146n.s. Right-sided adenomas6270n.s. Hyperplastic polyps (n) Hyperplastic polyps < 10 mm Carcinomas (n)45n.s. * all adenomas / all participants

Adenoma detection rates (i.e. percentage of patients with one or more adenomas) in large-scale screening and colonoscopy studies in various countries Author and year n Type of Adenoma rate Colonoscopy* Colonoscopy* USA Kanna D, S14.5% Barclay S23.5% Lieberman S37.5%Germany Sieg D20% Hüppe S10% Adler D, S16% Present study1256S22%Poland Regula 43042S9.4%Israel Rainis 10866D5% Asia Byeon 860S18.5% * D=diagnostic colonoscopy, S=screening colonoscopy

NBI-Study: Results: There was no difference between the two groups in terms of general ADR (0.32 vs. 0.34), the total number of adenomas (200 vs. 216) or in detection in subgroups of adenomas. This was despite a minimal, but significant longer withdrawal time in the NBI group (8.5 vs. 7.9 min, p<0.05).

NBI-Study: Conclusions: This large randomized trial in a homogeneous private practice screening setting could not demonstrate any objective benefit of the NBI technique in terms of improved adenoma detection rate. Contrast enhancement in conventional imaging techniques will likely not contribute to a reduction in adenoma miss rates for experienced colonoscopists.